source
- Alnylam commits $30 million upfront to AI startup Inceptive for RNA research collaborationAlnylam Pharmaceuticals announced a new collaboration with Inceptive, a Silicon Valley biotech startup that focuses on RNA. The agreement includes an upfront payment of $30 million and is intended…
- Eli Lilly says its GLP-1 weight loss shot and pill now covered for millions of AmericansEli Lilly announced that its GLP-1 based weight-loss injection and oral medication have been added to the formularies of the three largest pharmacy benefit managers. The company said this move make…